Clinical trials
Completed Scleroderma, Diffuse trials in Canada
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
19 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2009 | 1 |
| 2010 | 2 |
| 2013 | 1 |
| 2014 | 1 |
| 2017 | 1 |
| 2018 | 3 |
| 2019 | 3 |
| 2020 | 1 |
| 2021 | 2 |
| 2024 | 1 |
| 2025 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 19 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lady Davis Institute | 9 |
| London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | 3 |
| Dinesh Khanna, MD, MS | 1 |
| Genentech, Inc. | 1 |
| MedImmune LLC | 1 |
| MediQuest Therapeutics | 1 |
| Pfizer | 1 |
| Tanabe Pharma America, Inc. | 1 |
| United Therapeutics | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Scleroderma, Diffuse | 19 |
| Scleroderma, Systemic | 15 |
| Raynaud Disease | 2 |
| Skin Diseases | 2 |
| Anxiety Disorders | 1 |
| COVID-19 | 1 |
| Connective Tissue Diseases | 1 |
| Coronavirus Infections | 1 |
| Hypertension, Pulmonary | 1 |
| Lung Diseases, Interstitial | 1 |
Trials
Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.